Total Valuation
Sanofi has a market cap or net worth of €89.99B. The enterprise value is €108.09K.
Market Cap€89.99B
Enterprise Value€108.09K
Share Statistics
Sanofi has 1,216,634,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,216,634,900
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Sanofi’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 7.70%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)7.70%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee624.16K
Profits Per Employee65.99K
Employee Count74,846
Asset Turnover0.37
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sanofi is 22.8. Sanofi’s PEG ratio is 0.28.
PE Ratio22.8
PS Ratio2.16
PB Ratio1.41
Price to Fair Value1.41
Price to FCF11.23
Price to Operating Cash Flow5.16
PEG Ratio0.28
Income Statement
In the last 12 months, Sanofi had revenue of 46.72B and earned 7.81B in profits. Earnings per share was 6.40.
Revenue46.72B
Gross Profit33.67B
Operating Income9.60B
Pretax Income6.02B
Net Income7.81B
EBITDA12.48B
Earnings Per Share (EPS)6.40
Cash Flow
In the last 12 months, operating cash flow was 17.27B and capital expenditures -793.00M, giving a free cash flow of 16.48B billion.
Operating Cash Flow17.27B
Free Cash Flow16.48B
Free Cash Flow per Share13.54
Dividends & Yields
Sanofi pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.44
52-Week Price Change-5.47%
50-Day Moving Average75.65
200-Day Moving Average76.98
Relative Strength Index (RSI)45.53
Average Volume (3m)7.96K
Important Dates
Sanofi upcoming earnings date is Oct 30, 2026, Before Open (Confirmed).
Last Earnings DateJul 30, 2026
Next Earnings DateOct 30, 2026
Ex-Dividend Date―
Financial Position
Sanofi as a current ratio of 1.09, with Debt / Equity ratio of 34.07%
Current Ratio1.09
Quick Ratio1.09
Debt to Market Cap0.18
Net Debt to EBITDA1.04
Interest Coverage Ratio15.33
Taxes
In the past 12 months, Sanofi has paid 1.04B in taxes.
Income Tax1.04B
Effective Tax Rate0.17
Enterprise Valuation
Sanofi EV to EBITDA ratio is 9.13, with an EV/FCF ratio of 12.67.
EV to Sales2.44
EV to EBITDA9.13
EV to Free Cash Flow12.67
EV to Operating Cash Flow10.59
Balance Sheet
Sanofi has €6.35B in cash and marketable securities with €23.58B in debt, giving a net cash position of -€17.23B billion.
Cash & Marketable Securities€6.35B
Total Debt€23.58B
Net Cash-€17.23B
Net Cash Per Share-€14.16
Tangible Book Value Per Share€3.40
Margins
Gross margin is 72.77%, with operating margin of 20.54%, and net profit margin of 16.72%.
Gross Margin72.77%
Operating Margin20.54%
Pretax Margin12.89%
Net Profit Margin16.72%
EBITDA Margin26.71%
EBIT Margin14.56%
Analyst Forecast
The average price target for Sanofi is €94.40, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€94.40
Price Target Upside18.61% Upside
Analyst ConsensusModerate Buy
Analyst Count9
Revenue Growth Forecast15.30%
EPS Growth Forecast-35.58%